Dr. Jesus Gildardo Ulloa, MD

Dr. Ulloa practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Ulloa's NPI, 1306135579, was assigned on March 28, 2011. Dr. Ulloa graduated from UC Irvine School of Medicine in 2011. Dr. Ulloa holds California license A123518.

Dr. Ulloa's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Ulloa's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Ulloa is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Gonda (Goldschmied) Vascular Center. Dmand AI also links Dr. Ulloa to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ulloa practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Ulloa's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Ulloa is board certified in surgery by the American Board of Surgery. Dr. Ulloa is licensed in California.

Dmand AI lists circulatory problems in extremities among the conditions Dr. Ulloa treats.

CMS data shows 384 Medicare services from Dr. Ulloa across 5 procedure codes in 2024, for 250 Medicare patients. Medicare paid $26,471 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 250 Medicare patients who saw Dr. Ulloa in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ulloa's median patient age at 59, with 51% women.

In 2017, Dr. Ulloa wrote 23 Medicare Part D claims. They cover 2 drugs, with $132 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ulloa for performance year 2024, reported as part of a group. Dr. Ulloa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ulloa as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Ulloa, published from 2014 to 2017. Dr. Ulloa's most frequent co-authors are Anna Camille Bettini, MD, Alice Huan-Mei Chen, MD, MPH and Hobart W. Harris, MD.

CMS Open Payments shows 100 general payments to Dr. Ulloa from 11 drug and device companies from 2016 to 2025. Grants make up the largest share, 64% of the total. Medtronic Vascular, Inc. paid the most, $16,470.

Dr. Ulloa graduated from UC Irvine School of Medicine in 2011. Dr. Ulloa is a member of ACS.

Dr. Ulloa is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.